TCRL antibodies targeting HLA-A2/HTLV-I Tax peptide complex (Adicet)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTCRL antibodies targeting HLA-A2/HTLV-I Tax peptide complex (Adicet)

Drug Alias NameHuman recombinant T-Cell Receptor-Like antibodies (Adicet)Human recombinant T-Cell Receptor-Like antibodies (Applied Immune Technologies)Human recombinant TCRL antibodies (Adicet)Human recombinant TCRL antibodies (Applied Immune Technologies)TCRL antibodies targeting HLA-A2/HTLV-I Tax peptide complex (Applied Immune Technologies)

ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionHLA Class I Histocompatibility Antigen, A-2 alpha Chain modulators

TargetsHLA Class I Histocompatibility Antigen, A-2 alpha Chain

Therapy Area/IndicationsHTLV-I Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAdicet Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAdicet Bio Inc

Active IndicationsN/A

Inactive IndicationsHTLV-I Infections

Other Information

ATC CodeN/A